Kapitalfond øger bud på svensk medicinalselskab

Kapitalfonden EQT gør endnu et forsøg på at overtage det svenske medicinalselskab Karo Pharma, som fonden i oktober tilbød at købe for 5,97 mia. svenske kr.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app